Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study. Paolicelli D, Manni A, Direnzo V, D'Onghia M, Tortorella C, Zoccolella S, Trojano M J Clin Pharmacol. 2015 Apr 23. PMID: 25903516. Abstract CommentRecommendBookmarkWatch